medigraphic.com
ISSN 2078-7170 (Electronic)

2015, Number 3

<< Back Next >>

CorSalud 2015; 7 (3)

Incidence and characterization of peripartum cardiomyopathy at the Hospital do Prenda

Martínez GG, Alves LCG, Simba J, Triana GLM

Language: Spanish
References: 20
Page: 169-174
PDF size: 241.63 Kb.


ABSTRACT

Introduction: Peripartum cardiomyopathy is a rare disease that occurs in healthy women and is characterized by the development of left ventricular systolic dysfunction and symptoms of heart failure in the period between the last month of pregnancy and the first five months postpartum.
Objectives: To determine the incidence, presentation forms, treatment and mortality of patients received at the hospital.
Method: Prospective study of 13 patients diagnosed with peripartum cardiomyopathy who were received at the do Prenda Hospital from July 2012 to July 2013. Demographic variables, risk factors, gynecological and obstetrical history, signs and symptoms of heart failure, echocardiographic findings and treatment used were analyzed.
Results: The mean age was 30.8 ± 7.23 years, patients over 35 prevailed (38.5%). Most were multiparous (84.6%), with more than three pregnancies (61.5%), hypertensive disease of pregnancy was the main risk factor found (53.8%). Eleven patients were diagnosed during the first weeks postpartum. The mean ejection fraction was 36.8 ± 10%. Spironolactone, other diuretics and digitalis were the most frequently used drugs. There were no deaths during hospitalization.
Conclusions: Symptoms and signs of heart failure with reduced ejection fraction and use of digitalis and diuretics were the distinguishing characteristics of these patients, similar to those reported in international registries. The incidence of this disease is very low and there were no deaths in the period studied.


REFERENCES

  1. Urbanetz AA, Carraro EA, Kalache LF, Kalache PF, Lobo PHF, Germiniani H, et al. Cardiomiopatia peri-parto. Femina. 2009;37:13-8.

  2. da Costa C, Garcia S, Borges VT, Guimarães C, Si-mões EF, Bojikian B. Clinical characteristics asso-ciated with unfavorable outcomes in peripartum myocardiopathy. Arq Bras Cardiol. 2005;84:141-6.

  3. Ruiz Bailén M, López Martínez A, Fierro Rosón LJ. Miocardiopatía periparto. Med Clin (Barc). 2000; 114:551-7.

  4. Chacón C, Bisogni C, Cursack G, Zapata G. Miocar-diopatía periparto. Rev Fed Arg Cardiol. 2006;35: 125-9.

  5. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44: 1053-61.

  6. Feitosa HN, Moreira JLC, Diógenes IMS, Vieira MF, Eleutério FJC. Peripartum cardiomyopathy. Femina. 2005;33:387-93.

  7. Gama Pinto C, Colaço J, Maya M, Avillez T, Casal E, Hermida M. Miocardiopatia periparto. Acta Med Port. 2007;20:447-52.

  8. Avila WS, de Carvalho ME, Tschaen CK, Rossi EG, Grinberg M, Mady C, et al. Pregnancy and peripar-tum cardiomyopathy. A comparative and prospec-tive study. Arq Bras Cardiol. 2002;79:484-93.

  9. Nobre F, Serrano CV. Tratado de cardiología SOCESP. Barueri, São Paulo: Manole; 2005. p. 1523-4.

  10. 10.Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyo-pathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283:1183-8.

  11. 11.Sliwa K, Fett J, Elkayam U. Peripartum cardiomyo-pathy. Lancet. 2006;368:687-93.

  12. Mayosi BM. Contemporary trends in the epide-miology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart. 2007;93: 1176-83.

  13. 13.Demakis JG, Rahimtoola SH. Peripartum cardiomyo-pathy. Circulation. 1971;44:964-8.

  14. 14.Selle T, Renger I, Labidi S, Bultmann I, Hilfiker-Klei-ner D. Reviewing peripartum cardiomyopathy: cur-rent state of knowledge. Future Cardiol. 2009;5: 175-89.

  15. 15.Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prog-nosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc. 2005;80:1602-6.

  16. 16.Herrera-Villalobos JE, Sil PA, Pinal FM, Garduño A, Santamaría AM, Rueda JP. Índice aterogénico como factor de riesgo para el síndrome de preeclampsia. CorSalud [Internet]. 2012 [citado 13 Oct 2014];4: 261-5. Disponible en: http://www.corsalud.sld.cu/sumario/2012/v4n4a12/iaterogenico.html

  17. 17.Zambrano JM, Herrera JE, Mendoza F, Adaya EA, Morales JA, Díaz LA. Gasto cardíaco materno como predictor del síndrome de preeclampsia-eclampsia. CorSalud [Internet]. 2012 [citado 13 Oct 2014];4: 87-91. Disponible en: http://www.corsalud.sld.cu/sumario/2012/v4n2a12/gastocardiaco.htm

  18. 18.Lim CP, Sim DK. Peripartum cardiomyopathy: expe-rience in an Asian tertiary centre. Singapore Med J. 2013;54:24-7.

  19. 19.Prasad GS, Bhupali A, Prasad S, Patil AN, Deka Y. Peripartum cardiomyopathy - case series. Indian Heart J. 2014;66:223-6.

  20. 20.Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, et al. different characteristics of peripartum cardiomyopathy between patients complicated with and without hyperten-sive disorders. Results from the Japanese Nation-wide Survey of Peripartum Cardiomyopathy. Circ J. 2011;75:1975-81.




2020     |     www.medigraphic.com